VectorB2B is @ EIC Service Catalogue
We are part of the EIC Service Catalogue, supporting beneficiaries in both preclinical and clinical development
We are part of the EIC Service Catalogue, supporting beneficiaries in both preclinical and clinical development
VectorB2B is managing Technophage Ph 1b/2a Clinical Trial of TZ-161 for Acute Spinal Cord Injury – Portugal and Spain
VectorB2B design and execute your preclinical GLP/ non-GLP toxicology studies, ensuring the success of your drug/health product development program while meeting global standards and specifications for quality and compliance